Skip to main content
KANABO GROUP PLC logo

KANABO GROUP PLC — Investor Relations & Filings

Ticker · KNB ISIN · GB00BYQCS703 LEI · 213800XPJFSNWJIYKN52 IL Manufacturing
Open in API
Filings indexed 247 across all filing types
Latest filing 2021-07-26 M&A Activity
Country GB United Kingdom
Listing IL KNB

About KANABO GROUP PLC

https://www.kanabogroup.com/

Kanabo Group PLC is a digital health company focused on the research, development, and commercialization of cannabis-derived products. The company distributes cannabis-derived formulations for medical patients and non-THC products for CBD consumers. Its research and development efforts create proprietary, patent-pending formulas for conditions such as sleep and central nervous system (CNS) disorders. A key component of its offering is the VapePod®, a medically certified vaporization device that enables precise, metered-dosing of cannabis extracts. The company also operates The GP Service, a telehealth platform providing digital health services, including video consultations and online prescriptions, which integrates primary care with its specialist medicine offerings.

Recent filings

Filing Released Lang Actions
Proposed Acquisition
M&A Activity Classification · 98% confidence The document begins with an 'RNS Number' and is dated July 26, 2021. It announces a 'Proposed Acquisition' of another company (Materia) and details the terms, including the issue of shares and a loan facility. The text concludes with standard RNS disclaimers, indicating it is a regulatory news service announcement. Since this is a significant corporate action announcement (M&A/Takeover related) distributed via RNS, it fits best under the general 'Regulatory Filings' category (RNS) or potentially 'M&A Activity' (TAR). Given the structure and the explicit RNS header/footer, RNS is the most accurate classification for the distribution mechanism, although TAR describes the content. Since the definitions prioritize specific content types, and this is a major corporate transaction announcement, TAR (M&A Activity) is highly relevant. However, the document is a formal announcement of a transaction, not a prospectus or definitive agreement. Since the content is clearly about a takeover proposal, TAR is the most specific content classification. If TAR was not available, RNS would be the fallback. Given the explicit mention of 'Proposed Acquisition' and 'Reverse Take-over' (RTO), TAR is the primary fit.
2021-07-26 English
Block Listing Application
Share Issue/Capital Change Classification · 99% confidence The document is a formal announcement disseminated via RNS (Regulatory News Service) of the London Stock Exchange, indicated by the 'RNS Number' and the concluding boilerplate text identifying RNS as the Primary Information Provider. The content announces a 'Block Listing Application' to the LSE and FCA for new ordinary shares related to the exercise of outstanding warrants. This type of announcement, concerning capital structure changes (specifically related to share issuance/warrants) and regulatory notification, fits best under the general 'Regulatory Filings' category (RNS) as it is not a specific financial report (like 10-K or IR), a management change (MANG), or a dividend notice (DIV). While it relates to capital, it is an announcement about the administrative process of listing shares, making RNS the most appropriate general regulatory filing code, especially given the short length and nature of the filing.
2021-07-22 English
Kanabo’s First Medical Cannabis Product in UK
Regulatory Filings Classification · 100% confidence The document begins with 'RNS Number : 1401F' and is dated '14 July 2021'. It announces a significant business development: 'Kanabo's First Medical Cannabis Product in UK' and details the shipment and availability of their cartridges. The presence of the RNS header, the nature of the announcement (a specific operational milestone/product launch), and the concluding boilerplate text referencing RNS and the FCA strongly suggest this is a regulatory news service announcement. Since it is a general, timely announcement that doesn't fit perfectly into specific categories like ER, DIV, or CAP, the most appropriate classification is the general regulatory filing category.
2021-07-14 English
Issue of Equity
Share Issue/Capital Change Classification · 98% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange.' The content details an 'Issue of Equity' resulting from the exercise of warrants, leading to an increase in the total issued share capital and voting rights. This is a specific corporate action announcement related to capital structure changes, which aligns closely with the 'Share Issue/Capital Change' definition (SHA). However, since it is a general regulatory announcement distributed via RNS concerning a capital change, and RNS is the primary identifier, I must check if SHA is more specific than RNS. The document describes a specific capital change (issuance of shares following warrant exercise). The 'Share Issue/Capital Change' (SHA) category is more specific than the general 'Regulatory Filings' (RNS) fallback. Therefore, SHA is the most appropriate classification.
2021-07-08 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is a short announcement (2220 characters) released via RNS (London Stock Exchange's news service). The content explicitly states the 'Total Voting Rights' figure (368,516,290 Ordinary Shares) to be used by shareholders for FCA Disclosure Guidance and Transparency Rule notifications. This type of announcement, which provides a specific regulatory metric update without being a full financial report or a director's dealing report, fits best under the general regulatory announcement category, RNS, as it is a mandatory disclosure disseminated through the RNS system.
2021-06-30 English
Appointment of Director & Grant of Options
Regulatory Filings Classification · 98% confidence The document is an official announcement released via RNS (RNS Number: 3962D) on June 29, 2021. The primary content announces the appointment of a new Non-Executive Director (Dr Daniel Poulter MP) and details the grant of share options to him as part of his appointment. The latter half of the document contains a structured table detailing 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them,' specifically noting the grant of options. This structure strongly indicates a disclosure related to insider transactions or director dealings, which aligns with the definition for Director's Dealing (DIRS). While it is a regulatory announcement (RNS), the specific nature of the content (director appointment + option grant disclosure) makes DIRS a more precise classification than the general RNS fallback.
2021-06-29 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.